HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
Heat shock protein 90 (HSP90) is a vital chaperone protein, regulating signaling pathways and correcting misfolded proteins in cancer cells by interacting with oncogenic client proteins and co-chaperones. The inhibition of HSP90 chaperone machinery has been demonstrated as a potential approach with...
Saved in:
Published in | Oncology reports Vol. 49; no. 1; p. 1 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Athens
Spandidos Publications
01.01.2023
Spandidos Publications UK Ltd D.A. Spandidos |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!